Proactive Analysis of Specialized Databases

Size: px
Start display at page:

Download "Proactive Analysis of Specialized Databases"

Transcription

1 Proactive Analysis of Specialized Databases Using Visual Analytics to Expose Patterns and Trends Presented by: Ronald Stanko, Chief Deputy Attorney General Robert Dintino, Senior Supervisory Special Agent A cooperative effort between Visual Analytics Inc. and the Pennsylvania Office of the Attorney General

2 What is the PDMP Program? A Prescription Drug Monitoring Program (PDMP) is operated by a state and used to collect data on Schedule II through V controlled substances from pharmacies that dispense prescriptions within the state. 39 States have PDMP 33 States are operational PDMPs are designed to support education, treatment, track trends, help with drug abuse prevention, and monitor for non-compliant behaviors of patients and practitioners.

3 What are Schedule II Drugs? Schedule II drugs have a high potential for abuse and severe dependence, but have a currently accepted medical use. Schedule II drugs include: Amphetamine (Dexedrine, Adderall, Obetrol) Fentanyl (Duragesic, Oralet, Actiq) Cocaine Methadone (Dolophine, Methadose, Amidone) Methamphetamine (Desoxyn, Crack, Speed) Methylphenidate (Concerta, Ritalin) Opium Oxycodone (OxyContin,Percocet, Endocet, Roxicodone) PCP DEA SCHEDULE II DRUG LISTING

4 Sample PDMP State Profiles* Michigan: Established: 1988 Monitors: Schedule II - V Volume: 15M annual Collected: Monthly Dispensers: 3,000 California: Established: 1939 Monitors: Schedule II, III Volume: 21M annual Collected: Monthly Dispensers: 155,000 Texas: Established: 1981 Monitors: Schedule II Volume: 3.3M annual Collected: Monthly Dispensers: 4,300 Pennsylvania : Established: 2002 Monitors: Schedule II Volume: 4.1M annual Collected: Monthly Dispensers: 3,500 *

5 Potential Abstract Use Scenario Use Visual Analytics and VisuaLinks to provide the first proactive analysis of the Schedule II PDMP data. Outcomes: Identify patterns of abuse Cross (state)border utilization Doctor shopping patterns Irregular filling patterns PDMP DATA

6 VisuaLinks Specialized Functionality Query Quickly identify unknown outliers in data Frequencies/Counts Combinations of values Ratios Expand Find indirect associations between different entities that would be missed using traditional methods. Indirect connections Non-obvious relationships Collusion among doctors/pharmacies View See data visually and spot anomalies faster Hot spots (locations/pharmacies/etc) Network diagrams Temporal & Geospatial patterns Report Produce high-quality, finished output

7 Analytical Models For PDMP Data SUBJECT PRESCRIPTION PHYSICIAN PHARMACY **

8 VisuaLinks Summary Summary of Doctors Seen: Identified an individual who was seen by 179 physicians within the time-frame of the Class II data. Summary of Prescriptions Filled: Identified an individual who was issued 367 prescriptions for Class II medications within the time-frame of the Class II data.

9 One-Many-Many This view shows the relationship between a SUBJECT (left), to PRESCRIPTION (middle), and the related PHYSICIAN (right) SUBJECT PRESCRIPTION PHYSICIAN

10 Doctor Shopping Pattern PHYSICIAN-A PHYSICIAN-B Target suspect is related to multiple doctors for the same prescription-types SUBJECT PHYSICIAN-C PHYSICIAN-D PHYSICIAN-E PHYSICIAN-F PHYSICIAN-G

11 Multiple Pharmacy Usage ECKERD GIANT PHARMACY Target suspect uses multiple pharmacies to fill his prescriptions SUBJECT ACME PHARMACY WALGREEN DRUG STORE CVS PHARMACY The structure of this pattern is virtually identical to the doctor-shopping pattern RITE-AID PHARMACY

12 Sample Temporal Pattern For The Prescription Fill Date JAN FEB Prescription filled multiple time during the same week MAR APR MAY JUN JUL AUG SEP OCT Even on Christmas Day! NOV DEC

13 Geo-spatial Patterns in PDMP Data System can expose Geo-spatial patterns where a subject is filling prescriptions at different locations to try and avoid detection. filter on drug-type filter on date/times filter on locations filter on distances

14 Visual Analytics Summary Quickly identifies the extremes in any data set. Establishing outliers Using any combination of values Easily detects high-value targets Adds-value to source data Geo-encoding addresses Calculating meta-data about locations/dates/etc Expandable to include additional data sources State welfare and benefits data Law enforcement sources DIG database access (Server to Server) Promote cross-border sharing of PDMP data Identify larger-scope networks and patterns

15 Expected Discoveries of the Schedule II Data Identification of potential drug abuse by individuals. Identification of patterns related to drug trafficking. Identification of potential over-prescribing by physicians. Ability to customize and modify data on the fly to provide more relevance of the data captured to investigators. Ability to analyze data relevant to specific regulatory regions of a state to develop targeted responses to patterns and findings within the Schedule II data. Ability to proactive work to reduce the misuse of Schedule II drugs. Proactive analysis capabilities which were not available before the use of VisuaLinks.

16 Federated Searches Using High Value Aggregated Data Sets

17 Concept Determine the value and benefits of cross checking PA AG PDMP data against Appriss MethCheck and PC HIDTA data sets

18

19

20

21 Appriss MethCheck Data Pseudoephedrine sales database containing data compiled by pharmacies National scope Data can be organized by state Data contains consumer s name, driver s license or other identification, geocoded address, type of sale, geocoded location of sale

22 Retailers in the NPLEx network-march ,950 pharmacies

23

24 Methodology and Process Starting Point A group of PA AG PDMP interesting persons Process Use Visual Analytics Software to quickly cross reference the interesting persons against multiple data sets

25 Pennsylvania AG PDMP Data Top 100 people by most doctors visited Top 100 people by number of prescriptions written

26 Sample Interesting Persons Amy Bina Juan Carmona Christopher Hazeleaf James Sarchiapone Julia Arrivello Louis Kopistecki

27 Appriss Cross Reference Top 100 people by most doctors visited 133 Results from PA 637 Results from DC, MD, NJ, NY, PA, VA Top 100 people by number of prescriptions 97 Results from PA 509 Results from DC, MD, NJ, NY, PA, VA

28 PC HIDTA Cross Reference Top 100 people by most doctors visited 1,013 Results from 14 data sources Top 100 people by number of prescriptions 919 Results

29 Next Steps?? Who in the result sets are the same? Entity Resolution Address Standardization Identify cross border activity and in-state hot spots Driver s License Analysis Review, Validation, and Commonality

30 Trending and Behavioral Analysis Correlation surrounding events Sporting events, holidays, concerts, etc Correlation around hospital admissions Overdoses, preferred drug trends

31 Summary There exists a great power potential in using federated searches against currently available data sources Further investigation against interesting persons would likely be beneficial for all involved agencies

32 Questions?

North Dakota Board of Pharmacy

North Dakota Board of Pharmacy North Dakota Board of Pharmacy Updates on Drug Abuse Trends, the PDMP and Medical Marijuana Mark J. Hardy, Pharm D Executive Director Disclosure Statement I have no conflict of interests to report Objectives

More information

Harold Rogers Prescription Drug Monitoring Program Regional Meeting-Charleston, SC April 29, 2014 Andrew Holt, PharmD

Harold Rogers Prescription Drug Monitoring Program Regional Meeting-Charleston, SC April 29, 2014 Andrew Holt, PharmD Harold Rogers Prescription Drug Monitoring Program Regional Meeting-Charleston, SC April 29, 2014 Andrew Holt, PharmD National Epidemic Highlighted numerous studies/media reports State Epidemic Highlighted

More information

Arkansas Prescription Monitoring Program

Arkansas Prescription Monitoring Program Arkansas Prescription Monitoring Program ONE YEAR UPDATE Scott Pace, Pharm.D., Esq. Special Thanks Thanks to Denise Robertson at the Arkansas Department of Health for supplying the PMP data for this presentation

More information

Commonwealth of Kentucky NASCIO Recognition Awards Nomination Category: Data, Information and Knowledge Management. ekasper

Commonwealth of Kentucky NASCIO Recognition Awards Nomination Category: Data, Information and Knowledge Management. ekasper 2006 NASCIO Recognition Awards Nomination Category: Data, Information and Knowledge Management ekasper Cabinet for Health and Family Services The Enhanced Kentucky All Schedule Prescription Electronic

More information

MeDSS: a Data-Driven Tool for Pain Management

MeDSS: a Data-Driven Tool for Pain Management 1 MeDSS: a Data-Driven Tool for Pain Management Jaya Tripathi Scott Weiner, MD, MPH The International Conference on Opioids, Jun 11, 2017 2 Presentation Abstract Appropriate pain medication management

More information

Risk Classification Modeling to Combat Opioid Abuse

Risk Classification Modeling to Combat Opioid Abuse Risk Classification Modeling to Combat Opioid Abuse Improve Data Sharing to Identify High-Risk Prescribers of Opioids Christopher Sterling Chief Statistician NCI, Inc. www.nciinc.com 11730 Plaza America

More information

Challenges for U.S. Attorneys Offices (USAO) in Opioid Cases

Challenges for U.S. Attorneys Offices (USAO) in Opioid Cases Challenges for U.S. Attorneys Offices (USAO) in Opioid Cases Overview On August 2, 2017, U.S. Attorney General Jeff Sessions announced a pilot program whereby a new federal data analysis program is being

More information

4/24/15. New Mexico s Prescription Monitoring Program. Carl Flansbaum, RPh. PMP Director New Mexico Board of Pharmacy. New Mexico and the PMP

4/24/15. New Mexico s Prescription Monitoring Program. Carl Flansbaum, RPh. PMP Director New Mexico Board of Pharmacy. New Mexico and the PMP New Mexico s Carl Flansbaum, RPh. PMP Director New Mexico Board of Pharmacy New Mexico and the PMP In 2012, New Mexico had the 3 nd Highest Overdose Death Rate in Nation.! 492 Deaths or a rate of 23.6

More information

6/7/2017. MeDSS: a Data-Driven Tool for Pain Management. Presentation Abstract. The Extent of the Opioid Problem. 200% increase in opioidrelated

6/7/2017. MeDSS: a Data-Driven Tool for Pain Management. Presentation Abstract. The Extent of the Opioid Problem. 200% increase in opioidrelated 1 MeDSS: a Data-Driven Tool for Pain Management Jaya Tripathi Scott Weiner, MD, MPH The International Conference on Opioids, June 11, 2017 2 Presentation Abstract Appropriate pain medication management

More information

Wisconsin Statewide Substance Abuse Prevention Training Wisconsin Dells June 12, 2015

Wisconsin Statewide Substance Abuse Prevention Training Wisconsin Dells June 12, 2015 Wisconsin Statewide Substance Abuse Prevention Training Wisconsin Dells June 12, 2015 1 Presenter Andrea Magermans Program Analyst of the Wisconsin PDMP Wisconsin Department of Safety and Professional

More information

Pennsylvania Prescription Drug Monitoring Program Trends,

Pennsylvania Prescription Drug Monitoring Program Trends, DEA Intelligence Report Brief DEA-PHL-DIR-006-17 Pennsylvania Prescription Drug Monitoring Program Trends, 2014-2015 December 2016 1 Executive Summary The abuse and diversion of pharmaceutical drugs, particularly

More information

Controlled Substances Board

Controlled Substances Board Controlled Substances Board Report 1 July 1 September 30, 2016 Contact Information Wisconsin Controlled Substances Board Chairperson: Doug Englebert Members: Englebert, Doug, Chairperson Bloom, Alan, Vice

More information

Performance of North Carolina's System for Monitoring Prescription Drug Abuse. Session Law , Section 12F.16.(q)

Performance of North Carolina's System for Monitoring Prescription Drug Abuse. Session Law , Section 12F.16.(q) Performance of North Carolina's System for Monitoring Prescription Drug Abuse Session Law 2015-241, Section 12F.16.(q) Report to the Joint Legislative Oversight Committee on Health and Human Services and

More information

Arkansas Prescription Monitoring Program

Arkansas Prescription Monitoring Program Arkansas Prescription Monitoring Program FY 2016 Third Quarter Report January-March 2016 Arkansas Prescription Monitoring Program Quarterly Report January March, Fiscal year 2016 Act 304 of 2011 authorized

More information

Public Health Approaches to Substance Misuse and Addictions

Public Health Approaches to Substance Misuse and Addictions 35 th Annual Alaska Health Summit Public Health Approaches to Substance Misuse and Addictions Jay C. Butler, MD, FAAP, MACP, FIDSA Chief Medical Officer, Alaska Dept of Heath & Social Services Director,

More information

Chasing the Data: Monroe County Opioid-Related Data

Chasing the Data: Monroe County Opioid-Related Data Chasing the Data: Monroe County Opioid-Related Data Working Paper #2017-19 November 10, 2017 Janelle Duda-Banwar, MSW jmdgcj@rit.edu John Klofas, PhD John.klofas@rit,edu Irshad Altheimer, PhD ixagcj@rit.edu

More information

11/11/2015. MVAs Suicide Firearms Homicide. Where Can I Find A Copy of the PDMP Law? Why Was the Law Established? Why Was the Law Established?

11/11/2015. MVAs Suicide Firearms Homicide. Where Can I Find A Copy of the PDMP Law? Why Was the Law Established? Why Was the Law Established? Where Can I Find A Copy of the PDMP Law? Alabama Uniform Controlled Substances Act Code of Alabama 1975 20-2- (Article 10) -210 through 220 and Rules 420-7-2-.11 through.13 1 Why Was the Law Established?

More information

CONGRESSIONAL BRIEFING. PRESCRIPTION DRUG MONITORING PROGRAMS (PDMPs): CRITICAL DECISION SUPPORT TOOLS TO RESPOND TO THE OPIOID CRISIS

CONGRESSIONAL BRIEFING. PRESCRIPTION DRUG MONITORING PROGRAMS (PDMPs): CRITICAL DECISION SUPPORT TOOLS TO RESPOND TO THE OPIOID CRISIS CONGRESSIONAL BRIEFING PRESCRIPTION DRUG MONITORING PROGRAMS (PDMPs): CRITICAL DECISION SUPPORT TOOLS TO RESPOND TO THE OPIOID CRISIS SEPTEMBER 8, 2017 12:00 P.M. 1:00 P.M. RAYBURN 2075 (GROUND FLOOR)

More information

NYSHFA/NYSCAL 16 th Annual Nurse Leadership Conference. Timothy J. Dewey Sr. Investigator NYS Bureau of Narcotic Enforcement.

NYSHFA/NYSCAL 16 th Annual Nurse Leadership Conference. Timothy J. Dewey Sr. Investigator NYS Bureau of Narcotic Enforcement. NYSHFA/NYSCAL 16 th Annual Nurse Leadership Conference Timothy J. Dewey Sr. Investigator NYS Bureau of Narcotic Enforcement May 2, 2018 1 May 2, 2018 2 Bureau Overview May 2, 2018 3 HISTORY 1850--Bureau

More information

Oregon s PDMP: An epidemiological assist tool

Oregon s PDMP: An epidemiological assist tool Oregon s PDMP: An epidemiological assist tool Todd Beran Center for Prevention and Health Promotion Oregon Health Authority PDMP TTAC Webinar February 13, 2013 1 Acknowledgements Lisa Millet, MSH, Section

More information

ANNUAL REPORT

ANNUAL REPORT ANNUAL REPORT - 2015 New Hampshire Prescription Drug Monitoring Program Report for July 1, 2014 June 30, 2015 Published October 2015 Table of Contents Executive Summary... 3-4 NH PDMP Background Information

More information

FGSZ Zrt. from 28 February 2019 till 29 February 2020 AUCTION CALENDAR: YEARLY YEARLY BUNDLED AT CROSS BORDER POINTS

FGSZ Zrt. from 28 February 2019 till 29 February 2020 AUCTION CALENDAR: YEARLY YEARLY BUNDLED AT CROSS BORDER POINTS AUCTION CALENDAR: YEARLY YEARLY BUNDLED AT CROSS BORDER POINTS FIRM CAPACITY - First Monday of July 01.06.2019* 01.07.2019 07:00 01.10.2019 04:00 01.10.2020 04:00 2019/2020 01.10.2020 04:00 01.10.2021

More information

Prescription Drug Monitoring Program (PDMP) Delaware. Information contained in this presentation is accurate as of November 2017

Prescription Drug Monitoring Program (PDMP) Delaware. Information contained in this presentation is accurate as of November 2017 Prescription Drug Monitoring Program (PDMP) Delaware Information contained in this presentation is accurate as of November 2017 Dr. Michael C. Dejos, PharmD, BCPS, LSSBB 2 Acknowledgements Christian Ruffin,

More information

Arkansas Department of Health

Arkansas Department of Health Arkansas Department of Health 4815 West Markham Street Little Rock, Arkansas 72205-3867 Telephone (501) 661-2000 Governor Mike Beebe Nathaniel Smith, MD, MPH, Interim Director and State Health Officer

More information

Presentation Overview

Presentation Overview Navigating the Changing Regulatory Enforcement Landscape Relating to Opioids Anna M. Grizzle Tizgel K.S. High Jerry Williamson, M.D. Presentation Overview Recent Enforcement Actions Physician s Perspective

More information

Oregon Prescription Drug Monitoring Program

Oregon Prescription Drug Monitoring Program Oregon Prescription Drug Monitoring Program 2013 Annual Report to the PDMP Advisory Commission PUBLIC HEALTH DIVISION Prescription Drug Monitoring Program Oregon Prescription Drug Monitoring Program 2013

More information

Interstate Variation in Prescribing of Opioid Pain Relievers and Benzodiazepines Karin A. Mack, PhD Associate Director for Science

Interstate Variation in Prescribing of Opioid Pain Relievers and Benzodiazepines Karin A. Mack, PhD Associate Director for Science Interstate Variation in Prescribing of Opioid Pain Relievers and Benzodiazepines Karin A. Mack, PhD Associate Director for Science National Center for Injury Prevention and Control Division of Analysis,

More information

Prescription Monitoring Program Center for Excellence, Brandeis University. April 10-12, 2012 Walt Disney World Swan Resort

Prescription Monitoring Program Center for Excellence, Brandeis University. April 10-12, 2012 Walt Disney World Swan Resort Prescription Monitoring Program Center for Excellence, Brandeis University April 10-12, 2012 Walt Disney World Swan Resort Accepted Learning Objectives: 1. Explain the current capabilities and contributions

More information

Although PDMPs are separately managed and maintained by each state or jurisdiction, the national network facilitates more uniformity among states.

Although PDMPs are separately managed and maintained by each state or jurisdiction, the national network facilitates more uniformity among states. NASCSA Statement for the Record as presented by Barbara A Carter, President, NASCSA Submitted to: Department of Health and Human Services, Food and Drug Administration, Opioid Policy Steering Committee

More information

Nebraska: What s Going On with the PDMP and HIE

Nebraska: What s Going On with the PDMP and HIE Nebraska: What s Going On with the PDMP and HIE Kevin C. Borcher, PharmD PDMP Program Director NeHII, Inc. BJA PDMP North Regional Meeting October 16, 2018 Nebraska PDMP Legislative Summary LB 237 (2011)

More information

Prescription Drug Monitoring Program

Prescription Drug Monitoring Program California Department of Justice Prescription Drug Monitoring Program May, 2016 Health and Safety Code section 11165. (a) To assist health care practitioners in their efforts to ensure appropriate prescribing,

More information

Identification of Specific Drugs and Drug Diversion in Drug Overdose Fatalities

Identification of Specific Drugs and Drug Diversion in Drug Overdose Fatalities Identification of Specific Drugs and Drug Diversion in Drug Overdose Fatalities Svetla Slavova, PhD Sara LaMantia, MS Terry Bunn, PhD Tracey Corey, MD 2016 Safe States Annual Meeting April 13, 2016, Albuquerque,

More information

CDC s Approach to Addressing the Opioid Overdose Epidemic

CDC s Approach to Addressing the Opioid Overdose Epidemic CDC s Approach to Addressing the Opioid Overdose Epidemic Sarah Bacon National Center for Injury Prevention and Control Division of Unintentional Injury Prevention June 23, 2016 500,000 drug overdose deaths

More information

Evaluation of National Academic Detailing Service on Naloxone Kit Prescription Rates in the Veterans Health Administration

Evaluation of National Academic Detailing Service on Naloxone Kit Prescription Rates in the Veterans Health Administration Evaluation of National Academic Detailing Service on Naloxone Kit Prescription Rates in the Veterans Health Administration Melissa LD Christopher, PharmD National Director Academic Detailing Program Office

More information

The Wisconsin Prescription Drug Monitoring Program. WI PDMP Timeline. PDMP Overview. What is a PDMP? PDMPs Across the Nation. Wisconsin.

The Wisconsin Prescription Drug Monitoring Program. WI PDMP Timeline. PDMP Overview. What is a PDMP? PDMPs Across the Nation. Wisconsin. The Wisconsin Prescription Drug Monitoring Program Wisconsin Nurses Association Jail Health Care Conference May 21, 2018 WI PDMP Timeline PDMP Overview January 2013 WI PDMP operational April 2017 WI epdmp

More information

VIRGINIA DEPARTMENT OF HEALTH OFFICE OF THE CHIEF MEDICAL EXAMINER

VIRGINIA DEPARTMENT OF HEALTH OFFICE OF THE CHIEF MEDICAL EXAMINER VIRGINIA DEPARTMENT OF HEALTH OFFICE OF THE CHIEF MEDICAL EXAMINER To promote and protect the health of all Virginians Fatal Drug Overdose Quarterly Report Edition 216.3 Publication Date: January 217 METHODS,

More information

Cincinnati Children s Hospital Medical Center PHO/OVPCA Constipation Initiative Monthly Report February 2018

Cincinnati Children s Hospital Medical Center PHO/OVPCA Constipation Initiative Monthly Report February 2018 Cincinnati Children s Hospital Medical Center PHO/OVPCA Constipation Initiative Monthly Report February 2018 Aim: Project focus to embed evidence based protocol for the treatment of Constipation in the

More information

Arkansas Prescription Monitoring Program

Arkansas Prescription Monitoring Program Arkansas Prescription Monitoring Program FY 2017 Second Quarter Report October December 2016 Arkansas Prescription Monitoring Program Quarterly Report October December, Fiscal year 2017 Act 304 of 2011

More information

Opioid Overview Admiral Brett P. Giroir, M.D.

Opioid Overview Admiral Brett P. Giroir, M.D. A S S I S TA N T S E C R E TA RY F O R H E A LT H Opioid Overview Admiral Brett P. Giroir, M.D. Assistant Secretary for Health Senior Advisor for Opioid Policy @HHS_ASH August 20, 2018 SUBSTANCE ABUSE

More information

Telehealth Data for Syndromic Surveillance

Telehealth Data for Syndromic Surveillance Telehealth Data for Syndromic Surveillance Karen Hay March 30, 2009 Ontario Ministry of Health and Long-Term Care Public Health Division, Infectious Diseases Branch Syndromic Surveillance Ontario (SSO)

More information

Prescription Drug Abuse Task Force Rx Report Card

Prescription Drug Abuse Task Force Rx Report Card San Diego County Prescription Drug Abuse Task Force 2016 Rx Report Card October 2016 Key Measures of Prescription Drug and Heroin Problems in San Diego County. Visit www.sandiegorxabusetaskforce.org for

More information

C U S T O M E R D R I V E N. B U S I N E S S M I N D E D.

C U S T O M E R D R I V E N. B U S I N E S S M I N D E D. MAPS Update May 4, 2018 Presented by Kim Gaedeke, Acting Deputy Director Department of Licensing and Regulatory Affairs Andrew Hudson, Manager Drug Monitoring Section BPL-MAPS@Michigan.gov 517-373-1737

More information

Sleep Market Panel. Results for June 2015

Sleep Market Panel. Results for June 2015 Sleep Market Panel Results for June 2015 Notes: o This is a monthly trending report of panel member data along with additional analysis by: Sleep labs affiliated with Hospitals vs. Independent Labs o Hospital

More information

Quantifying the Emerging Stimulant Threat for All Stakeholders

Quantifying the Emerging Stimulant Threat for All Stakeholders National Emerging Threats Initiative Quantifying the Emerging Stimulant Threat for All Stakeholders National Cocaine, Meth and Stimulant Summit November 12, 218 Fort Lauderdale, FL Supplies of Drugs Opioids

More information

AHLA. X. Federal Enforcement of Fraud and Abuse Involving Opioid Abuse and Diversion

AHLA. X. Federal Enforcement of Fraud and Abuse Involving Opioid Abuse and Diversion Fraud and Compliance Forum, October 2017. Click here to access audio. AHLA X. Federal Enforcement of Fraud and Abuse Involving Opioid Abuse and Diversion Michelle Bergholz Frazier Senior Vice President,

More information

Opioid Deaths in South Carolina. Daniela Nitcheva, PhD Division of Biostatistics Bureau of Public Health Statistics

Opioid Deaths in South Carolina. Daniela Nitcheva, PhD Division of Biostatistics Bureau of Public Health Statistics Opioid Deaths in South Carolina Daniela Nitcheva, PhD Division of Biostatistics Bureau of Public Health Statistics Death Certificates ICD-10 Codes Literal text for cause of death is sent to the National

More information

Multnomah County s biggest drug bust ever on February 23rd, 2017 This bust of more than 100 pounds of meth highlights a new trend in drug

Multnomah County s biggest drug bust ever on February 23rd, 2017 This bust of more than 100 pounds of meth highlights a new trend in drug Overview In July 2006, Oregon became the first state to require a prescription for products containing pseudoephedrine and ephedrine, such as cold and allergy medications. Mississippi implemented a similar

More information

State of California Department of Justice. Bureau of Narcotic Enforcement

State of California Department of Justice. Bureau of Narcotic Enforcement State of California Department of Justice Bureau of Narcotic Enforcement Prescription Drugs in the U.S. At least half of all Americans take one prescription drug regularly, with one in six taking three

More information

Kentucky All Schedule Prescription Electronic Reporting (KASPER)

Kentucky All Schedule Prescription Electronic Reporting (KASPER) Kentucky All Schedule Prescription Electronic Reporting (KASPER) Phyllis Millspaugh Manager, Behavioral Health Prevention and Promotion Kentucky Cabinet for Health and Family Services Using PDMP Data to

More information

Data Integration and Analysis for Improved Drug Overdose Surveillance in Kentucky

Data Integration and Analysis for Improved Drug Overdose Surveillance in Kentucky Data Integration and Analysis for Improved Drug Overdose Surveillance in Kentucky Svetla Slavova, PhD Terry Bunn, PhD Bureau of Justice Assistance Research-Practitioner Partnership & Data-Driven Pilots

More information

THE FDA DRUG APPROVAL PROCESS Under the Federal Food, Drug, and Cosmetic (FD&C) Act, FDA is responsible for ensuring that all new drugs are safe and

THE FDA DRUG APPROVAL PROCESS Under the Federal Food, Drug, and Cosmetic (FD&C) Act, FDA is responsible for ensuring that all new drugs are safe and THE FDA DRUG APPROVAL PROCESS Under the Federal Food, Drug, and Cosmetic (FD&C) Act, FDA is responsible for ensuring that all new drugs are safe and effective. Before any drug is approved for marketing

More information

Presentation Objectives

Presentation Objectives Oregon s PDMP 101 Lisa Millet, MSH, Section Manager Injury and Violence Prevention Section Center for Prevention and Health Promotion Oregon Health Authority Eugene Oregon PDO Summit April 20, 2016 1 Presentation

More information

The Wisconsin Prescription Drug Monitoring Program

The Wisconsin Prescription Drug Monitoring Program The Wisconsin Prescription Drug Monitoring Program DHS 2018 WI Opioid Forum April 12, 2018 Learning Objectives 1. How the WI epdmp supports healthcare professionals in making informed prescribing, dispensing

More information

KASPER Quarterly Threshold Analysis Report, Second Quarter 2016

KASPER Quarterly Threshold Analysis Report, Second Quarter 2016 KASPER Quarterly Threshold Analysis Report, Second Quarter 26 The Kentucky All Schedule Prescription Electronic Reporting System (KASPER) Quarterly Threshold Analysis Report is produced under a Prescription

More information

The Infection Control Doctor and Clostridium difficile infection. Dr David R Jenkins University Hospitals of Leicester NHS Trust, England

The Infection Control Doctor and Clostridium difficile infection. Dr David R Jenkins University Hospitals of Leicester NHS Trust, England The Infection Control Doctor and Clostridium difficile infection Dr David R Jenkins University Hospitals of Leicester NHS Trust, England 250 200 150 100 50 0 Monthly cases of Clostridium difficile (UHL

More information

Teaming Up for Safer Pain Management: Strategies for Effective Collaboration

Teaming Up for Safer Pain Management: Strategies for Effective Collaboration Teaming Up for Safer Pain Management: Strategies for Effective Collaboration Noah Nesin, MD, FAAFP, Vice President of Medical Affairs, Penobscot Community Health Care Felicity Homsted, PharmD, DPLA, Chief

More information

Project Update: Comparing South Dakota Prescription Drug Monitoring Program Law Enforcement Profile Requests to Criminal History Data

Project Update: Comparing South Dakota Prescription Drug Monitoring Program Law Enforcement Profile Requests to Criminal History Data Project Update: Comparing South Dakota Prescription Drug Monitoring Program Law Enforcement Profile Requests to Criminal History Data Presented to Bureau of Justice Assistance Harold Rogers Prescription

More information

Overview of the Radiation Exposure Doses of the Workers at Fukushima Daiichi Nuclear Power Station

Overview of the Radiation Exposure Doses of the Workers at Fukushima Daiichi Nuclear Power Station Click here for the corrections made < Reference > December 3, 212 Tokyo Electric Power Company Overview of the Radiation Exposure Doses of the Workers at Fukushima Daiichi Nuclear Power Station * As of

More information

Avian influenza in poultry, wild and captive birds (AI)

Avian influenza in poultry, wild and captive birds (AI) Avian influenza in poultry, wild and captive birds (AI) Analysis of ADNS data since 01/2018 Reporting period: 2018-01-01 2018-10-28 Data query: 2018-10-30 AGES DSR Austrian Agency for Health and Food Safety

More information

Opioid Abuse in Iowa Rx to Heroin. Iowa Governor s Office of Drug Control Policy January 2016

Opioid Abuse in Iowa Rx to Heroin. Iowa Governor s Office of Drug Control Policy January 2016 1 Opioid Abuse in Iowa Rx to Heroin Iowa Governor s Office of Drug Control Policy January 2016 Why Is This Important? 2 3 National Rx Painkiller Trends CDC, 2013 4 National Rx-Heroin Trends NIH, 2015 5

More information

VIRGINIA S OPIOID & HEROIN OVERDOSE EPIDEMIC

VIRGINIA S OPIOID & HEROIN OVERDOSE EPIDEMIC 1 VIRGINIA S OPIOID & HEROIN OVERDOSE EPIDEMIC Virginia Association of Counties November 14, 2016 The Honorable William A. Hazel, Jr., M.D. Secretary of Health and Human Resources 1999 - Estimated drug

More information

NIDA Quick Screen V1.0F1

NIDA Quick Screen V1.0F1 NIDA Quick Screen V1.0F1 Name:... Sex ( ) F ( ) M Age... Interviewer... Date.../.../... Introduction (Please read to patient) Hi, I m, nice to meet you. If it s okay with you, I d like to ask you a few

More information

INFORMATION BRIEF. Overview. Prescription Drug Abuse Among Young People

INFORMATION BRIEF. Overview. Prescription Drug Abuse Among Young People Product No. 2002-L0424-004 INFORMATION BRIEF AUGUST 2002 U. S. D E P A R T M E N T O F J U S T I C E Overview Prescription drugs, a category of psychotherapeutics that comprises prescription-type pain

More information

Role of PMPs in Preventing Substance Abuse National Conference of State Legislatures December 6, 2006 San Antonio, Tx

Role of PMPs in Preventing Substance Abuse National Conference of State Legislatures December 6, 2006 San Antonio, Tx Role of PMPs in Preventing Substance Abuse National Conference of State Legislatures December 6, 2006 San Antonio, Tx Nick Reuter Division of Pharmacologic Therapy Substance Abuse and Mental Health Services

More information

Comprehensive Opioid Abuse Program (COAP) Category 6 Grantees Call

Comprehensive Opioid Abuse Program (COAP) Category 6 Grantees Call Comprehensive Opioid Abuse Program (COAP) Category 6 Grantees Call BJA Update Tara Kunkel Senior Drug Policy Advisor IPA Bureau of Justice Assistance U.S. Department of Justice Challenges/Lessons Learned

More information

States' Attempts to Affect the Juvenile Drug-Crime Relationship Through Law and Policy

States' Attempts to Affect the Juvenile Drug-Crime Relationship Through Law and Policy States' Attempts to Affect the Juvenile Drug-Crime Relationship Through Law and Policy Deborah A. Reichmann, J.D., M.P.H. Jamie F. Chriqui, Ph.D., M.H.S. Presentation at the American Society of Criminology

More information

pwc Smoking Ban Economic Effect Analysis

pwc Smoking Ban Economic Effect Analysis pwc Smoking Ban Economic Effect Analysis November 17, 2005 Table of Contents Scope................................................................................ Methods and Conclusions................................................................

More information

Controlled Substance Monitoring in the Age of the Opioid Epidemic

Controlled Substance Monitoring in the Age of the Opioid Epidemic Controlled Substance Monitoring in the Age of the Opioid Epidemic Paul E. Hilliard, MS, MD Hospital Pain Committee Chair Department of Anesthesiology CME housekeeping I have no financial disclosures AKA,

More information

PDMP Tools to Identify Red Flag Situations

PDMP Tools to Identify Red Flag Situations PDMP Tools to Identify Red Flag Situations Prescription Drug Monitoring Programs CBI Baltimore, MD February 7, 2017 Grant Carrow, Ph.D. Project Consultant The Heller School for Social Policy and Management

More information

Kansas EMS Naloxone (Narcan) Administration

Kansas EMS Naloxone (Narcan) Administration Kansas EMS Naloxone (Narcan) Administration Executive Summary Kansas Board of Emergency Medical Services August 217 The following pages denote an ongoing trending of naloxone administration by Kansas Emergency

More information

Faster Cancer Treatment: Using a health target as the platform for delivering sustainable system changes

Faster Cancer Treatment: Using a health target as the platform for delivering sustainable system changes Faster Cancer Treatment: Using a health target as the platform for delivering sustainable system changes Organisation Name: Ko Awatea, Counties Manukau Health Presenter: Bob Diepeveen HRT 1520 Innovations

More information

State Epidemiology Outcomes Workgroup (SEOW)

State Epidemiology Outcomes Workgroup (SEOW) State Epidemiology Outcomes Workgroup (SEOW) MARYLAND STRATEGIC PREVENTION FRAMEWORK Advisory Council Meeting 31 January 213 SEOW Director, Linda Simoni-Wastila lsimoniw@rx.umaryland.edu Overview SEOW

More information

Public Health Federal Funding Request to Address the Opioid Epidemic

Public Health Federal Funding Request to Address the Opioid Epidemic Public Health Federal Funding Request to Address the Opioid Epidemic On December 4, 2017, in response to the President s recent declaration of the opioid epidemic as a public health emergency and the final

More information

SAFE OPIOID PRESCRIBING C.U.R.E.S. PROGRAM

SAFE OPIOID PRESCRIBING C.U.R.E.S. PROGRAM Sorin Buga, MD Associate Clinical Professor Department of Supportive Care City of Hope National Medical Center SAFE OPIOID PRESCRIBING C.U.R.E.S. PROGRAM Click to edit Master Presentation Date Disclosure

More information

Report to the Legislature: Impact of the Minnesota Prescription Monitoring Program on Doctor Shopping

Report to the Legislature: Impact of the Minnesota Prescription Monitoring Program on Doctor Shopping Minnesota Board of Pharmacy Report to the Legislature: Impact of the Minnesota Prescription Monitoring Program on Doctor Shopping Prepared By: Dr. Katrina Howard, PMP Pharmacist Consultant October 31,

More information

ANNUAL REPORT OF THE CORONER

ANNUAL REPORT OF THE CORONER ANNUAL REPORT OF THE CORONER 2007 STEVE MOORE SHERIFF-CORONER PUBLIC ADMINISTRATOR 7000 MICHAEL N.CANLIS BLVD. FRENCH CAMP, CA. 95231 (209) 468-4300 www.sjsheriff.org TABLE OF CONTENTS INTRODUCTION 1

More information

Harold Rogers Update Melissa McPheeters, PhD, MPH

Harold Rogers Update Melissa McPheeters, PhD, MPH Harold Rogers Update 2017 Melissa McPheeters, PhD, MPH We Need a New Normal Full collaboration among diverse departments Appropriate integration of data from disparate data sources Business intelligence

More information

U.S. Counties Vulnerability to Rapid Dissemination of HIV/HCV Infections Among People Who Inject Drugs

U.S. Counties Vulnerability to Rapid Dissemination of HIV/HCV Infections Among People Who Inject Drugs U.S. Counties Vulnerability to Rapid Dissemination of HIV/HCV Infections Among People Who Inject Drugs Michelle Van Handel, MPH Health Scientist National Center for HIV/AIDS, Viral Hepatitis, STDs and

More information

Using Prescription Drug Monitoring Program Data to Advance Prevention Planning

Using Prescription Drug Monitoring Program Data to Advance Prevention Planning September 13, 2016 Using Prescription Drug Monitoring Program Data to Advance Prevention Planning Emerging Drug Issues and Trends Chelsey Goddard, Director, SAMHSA s Center for the Application of Prevention

More information

Michael M. Miller, MD, FASAM, FAPA

Michael M. Miller, MD, FASAM, FAPA Michael M. Miller, MD, FASAM, FAPA mmiller@rogershospital.org Medical Director, Herrington Recovery Center (HRC) Rogers Memorial Hospital Oconomowoc, Wisconsin Vice Speaker Wisconsin Medical Society Clinical

More information

5/2/2016. Dr Brooks has no relevant financial affiliations to disclose. (Update 04/15/16) Learning Objectives

5/2/2016. Dr Brooks has no relevant financial affiliations to disclose. (Update 04/15/16) Learning Objectives Persistent Challenge of HIV Transmission Control in Injection Drug Use: The Indiana Outbreak John T. Brooks, MD Senior Medical Advisor, Division of HIV/AIDS Prevention National Center for HIV/AIDS, Viral

More information

Using the NC Controlled Substances Reporting System to Identify Providers Manifesting Unusual Prescribing Practices

Using the NC Controlled Substances Reporting System to Identify Providers Manifesting Unusual Prescribing Practices Using the NC Controlled Substances Reporting System to Identify Providers Manifesting Unusual Prescribing Practices Prevention Research Center Penn State December 2, 2015 Chris Ringwalt, DrPH* Sharon Schiro,

More information

DEA: Combating the Supply

DEA: Combating the Supply Drug Enforcement Administration DEA: Combating the Supply 2nd Annual Opioid Abuse and Heroin Overdose Solutions Summit Cathy Gallagher Diversion Program Manager Detroit Division May 11, 2017 1 Prescription

More information

April 26, New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Board of Pharmacy Prescription Monitoring Program (PMP)

April 26, New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Nurse Practitioner Council New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) Peter Ryba, PharmD PMP Director

More information

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot The SCS Snapshot is prepared by NDEWS Coordinating Center staff and contains graphics

More information

Winter Holiday Suicide Myth Continues to be Reinforced in Press Annenberg Public Policy Center Study Finds

Winter Holiday Suicide Myth Continues to be Reinforced in Press Annenberg Public Policy Center Study Finds FOR IMMEDIATE RELEASE DATE: 8 December 2010 CONTACT: Dan Romer, 215-898-6776 (office); 610-202-7315 (cell) Winter Holiday Suicide Myth Continues to be Reinforced in Press Annenberg Public Policy Center

More information

18 Week 92% Open Pathway Recovery Plan and Backlog Clearance

18 Week 92% Open Pathway Recovery Plan and Backlog Clearance 18 Week 92% Open Pathway Recovery Plan and Backlog Clearance Page 1 of 6 17.05.2012 1.0 Background 18-Week 92% Open Pathway RECOVERY PLAN The Trust has achieved compliance against the admitted and non-admitted

More information

BJA Performance Measures

BJA Performance Measures BJA Performance Measures Timothy J. Willis, Ph.D. Senior Research Associate, CSR, Inc. timothy.willis@ojp.usdoj.gov (202) 514-8045 At the end of this session you will be able to: 1. Explain the value of

More information

An Evaluation of the DoD Transdermal Fentanyl Pharmacy Edit. LTC Stacia Spridgen, MSC, USA Director, DoD Pharmacoeconomic Center

An Evaluation of the DoD Transdermal Fentanyl Pharmacy Edit. LTC Stacia Spridgen, MSC, USA Director, DoD Pharmacoeconomic Center An Evaluation of the DoD Transdermal Fentanyl Pharmacy Edit LTC Stacia Spridgen, MSC, USA Director, DoD Pharmacoeconomic Center 1 TRICARE Eligible Beneficiaries Monthly Average, FY08 Retirees & Family

More information

Cancer Immunotherapy Pilot Program/ Patents 4 Patients. USPTO BCP Customer Partnership Meeting Alexandria, VA August 2, 2017

Cancer Immunotherapy Pilot Program/ Patents 4 Patients. USPTO BCP Customer Partnership Meeting Alexandria, VA August 2, 2017 Cancer Immunotherapy Pilot Program/ Patents 4 Patients USPTO BCP Customer Partnership Meeting Alexandria, VA August 2, 2017 1 Cancer Immunotherapy Pilot Program/ Patents 4 Patients The United States Patent

More information

National Institute on Drug Abuse

National Institute on Drug Abuse National Institute on Drug Abuse Community Epidemiology Work Group (CEWG) NIDA Community Epidemiology Work Group 62 nd Semi- Annual Meeting June 2007 Seattle Honolulu Jim Hall Center for the Study and

More information

Prescription Drug Abuse National Perspective

Prescription Drug Abuse National Perspective Prescription Drug Abuse National Perspective Timothy P. Condon, Ph.D. Science Policy Advisor Office of the Director White House Office of National Drug Control Policy Commonly Abused Prescription Drugs

More information

System for Opioid Overdose Surveillance (S.O.S.) Mahshid Abir, MD, MSc Rebecca Cunningham, MD Amy Bohnert, PhD, MHS June 22, 2018

System for Opioid Overdose Surveillance (S.O.S.) Mahshid Abir, MD, MSc Rebecca Cunningham, MD Amy Bohnert, PhD, MHS June 22, 2018 System for Opioid Overdose Surveillance (S.O.S.) Mahshid Abir, MD, MSc Rebecca Cunningham, MD Amy Bohnert, PhD, MHS June 22, 2018 Disclosure This project is funded by the UM Injury Prevention Center, Michigan

More information

Six Years of Opioid-Involved Accidental and Undetermined Fatalities among Connecticut Residents,

Six Years of Opioid-Involved Accidental and Undetermined Fatalities among Connecticut Residents, Six Years of Opioid-Involved Accidental and Undetermined Fatalities among Connecticut Residents, 2009-2014 Lauretta E. Grau, Russell Skip Barbour, and Shawn M. Lang Background Heroin Deaths FDA efforts

More information

Methadone. Description

Methadone. Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.41 Subject: Methadone Page: 1 of 8 Last Review Date: March 18, 2016 Methadone Description Dolophine

More information

Data Visualization - Basics

Data Visualization - Basics Data Visualization - Basics The Visualization Process ACQUIRE PARSE FILTER MINE REPRESENT REFINE INTERACT Sales Data (US $ in thousands) Region Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Domestic

More information

Prescription Drug Abuse: Colorado and Nationwide

Prescription Drug Abuse: Colorado and Nationwide Prescription Drug Abuse: Colorado and Nationwide Eric Lavonas, MD Associate Director, Rocky Mountain Poison and Drug Center Associate Professor, University of Colorado School of Medicine 1 What s the Problem?

More information

Systematic Surveillance of Illicitly Manufactured Fentanyl Cases Initiated by Law Enforcement Steven P. Kurtz, PhD and Mance E.

Systematic Surveillance of Illicitly Manufactured Fentanyl Cases Initiated by Law Enforcement Steven P. Kurtz, PhD and Mance E. Systematic Surveillance of Illicitly Manufactured Fentanyl Cases Initiated by Law Enforcement Steven P. Kurtz, PhD and Mance E. Buttram, PhD Nova Southeastern University Center for Applied Research on

More information

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot The SCS Snapshot is prepared by NDEWS Coordinating Center staff and contains graphics

More information

1/29/2013. Schedule II Controlled Substances: Basics and Beyond. Controlled Substances. Controlled Substances, Schedule I

1/29/2013. Schedule II Controlled Substances: Basics and Beyond. Controlled Substances. Controlled Substances, Schedule I chedule II Controlled ubstances: Basics and Beyond James L. Besier, Ph.D., R.Ph., FAHP Adjunct Associate Professor College of Nursing Adjunct Assistant Professor James L. Winkle College of Pharmacy University

More information